Breast milk protects young infants against Campylobacter diarrhea by mechanisms which are not well understood. the long-term objective of this research project is to define components of human milk which interact with specific virulence traits of Campylobacter to prevent infection or disease.
the specific aims are to: 1) characterize milk antibodies directed against specific putative virulence factors of Campylobacter using the ligand binding assay in mammalian cells and by Western blots and to develop quantitative techniques to measure these specific antibodies in milk; 2) define the role of antibodies to specific virulence traits in protection using in vitro and in vivo models and ultimately to compare the levels of milk antibodies in infected and non- infected children from a nested case-control study from our previous cohort studies; 3) characterize and purify milk receptor glycoconjugates that inhibit infection with enteroinvasive Campylobacter by HPLC and identification of active compounds; 4) define the prevalence of fucosylated oligosaccharides in human milk among different populations and the relative variability over time during breastfeeding, and 5) define the role of fucosylated oligosaccharides in protection against infection and disease, by means of a nested case-control study and by conducting pilot studies in volunteers. The significance of this project is that it will define relevant antibodies and glycoconjugates that are protective against Campylobacter infection and will help to better understand the host-parasite interaction mucosa.

Project Start
Project End
Budget Start
Budget End
Support Year
15
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Eastern Virginia Medical School
Department
Type
DUNS #
City
Norfolk
State
VA
Country
United States
Zip Code
23501
Reed, Benjamin D; Schibler, Kurt R; Deshmukh, Hitesh et al. (2018) The Impact of Maternal Antibiotics on Neonatal Disease. J Pediatr 197:97-103.e3
Young, Bridget E; Patinkin, Zachary W; Pyle, Laura et al. (2017) Markers of Oxidative Stress in Human Milk do not Differ by Maternal BMI But are Related to Infant Growth Trajectories. Matern Child Health J 21:1367-1376
Dingess, Kelly A; Valentine, Christina J; Ollberding, Nicholas J et al. (2017) Branched-chain fatty acid composition of human milk and the impact of maternal diet: the Global Exploration of Human Milk (GEHM) Study. Am J Clin Nutr 105:177-184
He, YingYing; Lawlor, Nathan T; Newburg, David S (2016) Human Milk Components Modulate Toll-Like Receptor-Mediated Inflammation. Adv Nutr 7:102-11
Vanchiere, John A; Carillo, Berenice; Morrow, Ardythe L et al. (2016) Fecal Polyomavirus Excretion in Infancy. J Pediatric Infect Dis Soc 5:210-3
Ward, Doyle V; Scholz, Matthias; Zolfo, Moreno et al. (2016) Metagenomic Sequencing with Strain-Level Resolution Implicates Uropathogenic E. coli in Necrotizing Enterocolitis and Mortality in Preterm Infants. Cell Rep 14:2912-24
Newburg, David S; Ko, Jae Sung; Leone, Serena et al. (2016) Human Milk Oligosaccharides and Synthetic Galactosyloligosaccharides Contain 3'-, 4-, and 6'-Galactosyllactose and Attenuate Inflammation in Human T84, NCM-460, and H4 Cells and Intestinal Tissue Ex Vivo. J Nutr 146:358-67
He, YingYing; Liu, ShuBai; Kling, David E et al. (2016) The human milk oligosaccharide 2'-fucosyllactose modulates CD14 expression in human enterocytes, thereby attenuating LPS-induced inflammation. Gut 65:33-46
Currier, Rebecca L; Payne, Daniel C; Staat, Mary A et al. (2015) Innate Susceptibility to Norovirus Infections Influenced by FUT2 Genotype in a United States Pediatric Population. Clin Infect Dis 60:1631-8
Newburg, David S; Morelli, Lorenzo (2015) Human milk and infant intestinal mucosal glycans guide succession of the neonatal intestinal microbiota. Pediatr Res 77:115-20

Showing the most recent 10 out of 292 publications